Skip to main content

Month: March 2022

Paramount Global Utilizes Avid’s Managed Cloud to Transform Video Content Production Operations

Cloud hosted technology solutions provided by Avid optimize edit, storage and collaboration scaling for Paramount production teams globally BURLINGTON, Mass., March 17, 2022 (GLOBE NEWSWIRE) — Today, Avid® (Nasdaq: AVID) proudly announces an expansion of its managed cloud solution offering with a focus on an industry platform. Paramount Global (Nasdaq: PARA, PARAA), one of the world’s largest providers and producers of media and entertainment content, has entered into an agreement that offers Avid’s managed cloud solutions for video content production to creative teams around the globe. The companies’ new cloud subscription services agreement supports Paramount Tech’s “Cloud First” mindset, transforming production operations with rapidly scalable, centralized resources that relieve creative teams from the burden of infrastructure...

Continue reading

authID.ai to Report Fiscal Year 2021 Earnings on March 21

Conference call and webcast to be held at 8:30 a.m. EDT LONG BEACH, NY , March 17, 2022 (GLOBE NEWSWIRE) — authID.ai (Nasdaq: AUID), a leading provider of secure, mobile, biometric identity authentication announced that it will report financial results for the fiscal year ended December 31, 2021 on Monday, March 21, before market opening, instead of on March 22nd as previously announced. Following the earnings release, authID.ai Chief Executive Officer Tom Thimot, authID.ai President & CTO Tripp Smith, and authID.ai Chief Financial Officer Stu Stoller will host a webcast and conference call at 8.30 a.m. EDT to discuss the financial results and provide an update on recent developments. To listen to the webcast and view the presentation, investors can follow this link: https://edge.media-server.com/mmc/p/692723de. The slides...

Continue reading

VYNE Therapeutics Reports Year-End 2021 Financial Results and Provides Corporate Update

FMX114 demonstrated preliminary clinical safety and pharmacokinetics in Phase 1b study VYN201 shows promising preclinical data in 3 well-established and validated inflammation models BRIDGEWATER, N.J., March 17, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced financial results for the fourth quarter and year ended December 31, 2021 and provided a business update. “2021 was a transformative year for VYNE, we have made significant progress on our strategic focus to develop novel therapies for immuno-inflammatory conditions, leveraging our core drug development competencies. We completed the divestiture of our topical minocycline MST...

Continue reading

CorMedix Inc. Announces the Appointment of Chief Executive Officer

Joseph Todisco to join CorMedix as Chief Executive Officer; Brings significant experience in commercial strategy, business operations and leadership, and specialty pharmaceuticals industry BERKELEY HEIGHTS, N.J., March 17, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the appointment of Joseph Todisco as Chief Executive Officer of the company. Mr. Todisco also will join the CorMedix Board of Directors. The company expects Mr. Todisco to join CorMedix on May 16th or such earlier date as he completes his contractual responsibilities to his current employer. Myron Kaplan, Chairman of CorMedix’s Board of Directors commented, “We are delighted to welcome...

Continue reading

SFLMaven Provides Unaudited 2022 Year-to-Date Performance Metrics as Company Tracks Toward Record Growth in Core Vintage Jewelry Business

Sales up 26-30%, per-item pricing up 22%, and repeat buyers up 14% year over year FORT LAUDERDALE, FL, March 17, 2022 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC Pink: SFLM), (“SFLMaven” or the “Company”) (www.sflmaven.com), a leading provider of high-end luxury goods, is pleased to provide current and prospective investors with updated performance data for the year to date in 2022. Note: All data points discussed below are preliminary unaudited information, subject to change in future Company filings. “The second half of last year showed several dynamics that suggested a spur toward accelerating growth in our vintage jewelry business, but 2022 has dramatically exceeded our expectations thus far,” stated Joseph Ladin, CEO of SFLMaven. “At this point, we still have three Famous Thursday Night Auctions left in...

Continue reading

Branded Legacy, Inc. Signs Letter Of Intent To Acquire All In Extracts, LLC

Orlando, FL, March 17, 2022 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of hemp and cannabinoid-infused beverages, along with an array of CBD topicals and tinctures completes a letter of intent to acquire All In Extracts, LLC. Branded Legacy, Inc. signed a letter of intent to acquire All In Extracts, LLC d.b.a. Star Hill Hemp on Monday morning. Owned by Matt Grisham, Aaron Landerville, and Lorraine A, All In Extracts is located at 27003 Hickory Hill Rd, Brooksville, FL 34602. The potentially acquired Company is in the business of extraction and manufacturing of Delta-8, Delta-9, THC-O, and CBD products. All In Extracts also has its own brand called Star Hill Hemp to retail tinctures and gummies of its own making. The letter of intent represents basic terms agreed...

Continue reading

Diversey Announces Appointment of Eric Foss as Chairman of the Board

FORT MILL, S.C., March 17, 2022 (GLOBE NEWSWIRE) — Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, today announced that its Board of Directors has appointed Eric Foss as Chairman of the Board effective March 17. Foss succeeds Selim Bassoul who will remain a Director. Mr. Foss has been a Director since Diversey’s IPO in March 2021. “Eric is a highly successful leader, with a proven track record of driving growth, creating sustainable shareholder value, building high performance teams and creating a purpose driven legacy for global at scale companies,” said Phil Wieland, Diversey’s CEO. “I look forward to continuing to work with Phil, his team and the Board at such an exciting time as we continue to drive growth and long-term value for all key constituents –...

Continue reading

5E Executes Research Agreement That Aims to Enhance the Performance of Permanent Magnets Through Increased Boron Usage

HIGHLIGHTS5E to collaborate with world renowned U.S. institution, Georgetown University Research aims to enhance the performance of permanent magnets through increased boron usage Research has the potential to create novel intellectual property and commercialization pathways for 5E as it pertains to the manufacturing of boron enhanced permanent magnetsHOUSTON, March 17, 2022 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq:FEAM) (ASX:5EA) (“5E” or the “Company”) has entered into a research collaboration agreement with Georgetown University (“Georgetown”) for the advancement of boron based materials research in permanent magnets. Under the terms of the agreement, 5E will provide funds to and collaborate with Georgetown in exploring boron-based novel magnetic materials. This research has the potential to create intellectual...

Continue reading

Mondelēz International Announces an Increase of the Maximum Tender Amount and the Early Tender Results of Its Previously Announced Cash Tender Offer

CHICAGO, March 17, 2022 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (Nasdaq: MDLZ) (“Mondelēz International”) today announced the early tender results as of 5:00 p.m., New York City time, on March 16, 2022 (the “Early Tender Date”) for its previously announced offer to purchase (the “Tender Offer”) for cash up to an aggregate consideration amount, including premium, but excluding any Accrued Interest (as defined below), of $850,000,000 (such amount as it may be amended, the “Maximum Tender Amount”) of the debt securities listed in the table (the “Notes”) from each holder (individually, a “Holder,” and collectively, the “Holders”) of the applicable Notes, each issued under the applicable indenture, as supplemented by the applicable officers’ certificate, governing each series of Notes.Title ofSecurity CUSIP / ISIN Maturity...

Continue reading

ADDvantage Technologies Announces Cost-Reduction Initiative, Designed to Align Expenses with Growing 5-G Demand

With Initial 5-G-Related Scaling Complete, Company Eliminates $2.4 Million in Fulton-Related G&A, Expected to Be Evident in Second-Half of Fiscal Year CARROLLTON, Texas, March 17, 2022 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today announced a significant cost-reduction initiative, designed to improve operational efficiency and reduce costs following the initial ramp-up to meet the growing demand for 5-G and related tower work. As the Company has received more clarity into the pace and geographic distribution of 5-G work for the balance of the year, management has been able to reallocate resources and improve operational efficiency. Senior leadership has taken action, starting in March 2022, to reduce annual operating, general and administrative expenses...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.